news details |
|
|
| DSM Anti-Infectives launches ‘Purimox’ in Asia-Pacific | | |
Toansa (Punjab) | August 23
Global leader DSM Anti-Infectives
today announced the launch of its breakthrough technology in India, in succession to its first production facility in Spain with the introduction
of Purimox an antibiotic with highest purity. Speaking on the occasion of
the introduction of Purimox, Mr. Gerard De Reuver, President, DSM
Anti-Infectives said, "We have a long-term commitment to India. DSM is proud
to be in India, a country that has recognized the value and importance of a
strong biomedical and pharmaceutical industry. We will follow DSM's inherent
commitment to its relentless pursuit of scientific excellence and
innovation. India, over the years has become an important market with and
the new plant is part of our expansion plans to have a strong footing in the
region.''
Purimox, a penicillin based antibiotic, is from the DSM Pure ActivesTM
family of environmental friendly products. Purimox was introduced in Toansa, Punjab by Mr. Gerard De Reuver, the President of DSM
Anti-Infectives. Conventionally, amoxicillin is produced in a synthetic process using strong solvents and chemicals.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
